TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26957110

Group type: EXPERIMENTAL
Intervention: GS-9857 (100 mg once daily for 3 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GS-9857 (50-300 mg once daily for 3 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GS-9857
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25202935

Group type: EXPERIMENTAL
Intervention: Posterolateral lumbar fusion (PLF)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Posterior lumbar interbody fusion (PLIF)
Number of subjects: 81
Study: 23111749

Group type: EXPERIMENTAL
Intervention: Home monitoring of intraocular pressure and blood pressure measurements
Number of subjects: 70
Study: 20398447

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Collagen injection
Number of subjects: 0
Study: 18059586

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (400 IU vitamin E + 1 g vitamin C)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fruit and vegetable powder (FV)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (A)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (A) and FV
Number of subjects: 48
Study: 16918747

Group type: EXPERIMENTAL
Intervention: Condition-specific computerized templates for urinary incontinence (UI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Condition-specific computerized templates for falls
Number of subjects: 0
Study: 12794024

Group type: EXPERIMENTAL
Intervention: Pentoxifyllin (PTX) 30 mg/kg/day
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no PTX)
Number of subjects: 31
Study: 10695096

Group type: EXPERIMENTAL
Intervention: nifedipine GITS 20 mg once daily
Number of subjects: 49

Group type: COMPARATOR
Intervention: nifedipine retard 10 mg twice daily
Number of subjects: 49
Study: 8934359

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fosinopril (20 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 1913770

Group type: EXPERIMENTAL
Intervention: sucrose (S) and sucrose-Duraphat (SD)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: invert sugar (I) and invert sugar-Duraphat (ID)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Duraphat (D)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 187
Study: 6347085

Group type: EXPERIMENTAL
Intervention: 5‐FU + adriamycin + levamisole (LMS)
Number of subjects: 167

Group type: COMPARATOR
Intervention: 5‐FU + adriamycin (control group)
Number of subjects: 167
Study: 31835039

Group type: EXPERIMENTAL
Intervention: ALCAM measured at admission
Number of subjects: 5165
Study: 29550150

Group type: EXPERIMENTAL
Intervention: 400 IU vitamin D3 supplementation
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: 4000 IU vitamin D3 supplementation
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group (400 IU)
Number of subjects: 179
Study: 28415973

Group type: EXPERIMENTAL
Intervention: PREPARE intervention
Number of subjects: 5091

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 5091
Study: 25662474

Group type: EXPERIMENTAL
Intervention: Outpatient treatment
Number of subjects: 46

Group type: COMPARATOR
Intervention: Inpatient treatment (2-day admission)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Inpatient treatment
Number of subjects: 46
Study: 24615574

Group type: EXPERIMENTAL
Intervention: Audio Computer-Assisted Self-Interviewing (ACASI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Face-to-Face Interviewing (FTFI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Computer-Assisted Personal Interviewing (CAPI)
Number of subjects: 0
Study: 22703383

Group type: EXPERIMENTAL
Intervention: Event-related desynchronization (ERD) during hand motor imagery in ALS patients
Number of subjects: 19

Group type: COMPARATOR
Intervention: Event-related desynchronization (ERD) during hand motor imagery in healthy control subjects
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Bulbar function in ALS patients
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Motor function of the upper extremities in ALS patients
Number of subjects: 19
Study: 19799783

Group type: EXPERIMENTAL
Intervention: Treadmill with manual assistance (TM)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Treadmill with electrical stimulation (TS)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Overground with electrical stimulation (OG)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Treadmill with locomotor robot (LR)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Non-disabled (ND) individuals walking at preferred speed
Number of subjects: 51

Group type: COMPARATOR
Intervention: Non-disabled (ND) individuals walking at slower speed and using a walker
Number of subjects: 51
Study: 17577468

Group type: EXPERIMENTAL
Intervention: Intravenous/oral linezolid
Number of subjects: 163

Group type: COMPARATOR
Intervention: Intravenous vancomycin
Number of subjects: 163
Study: 15101639

Group type: EXPERIMENTAL
Intervention: Maglev train sounds (Transrapid 08)
Number of subjects: 0
Study: 11570615

Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Meloxicam
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 110
Study: 9458998

Group type: EXPERIMENTAL
Intervention: Fluid balance monitoring for two weeks (Group A)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No fluid balance monitoring (Group B)
Number of subjects: 12
Study: 7698835

Group type: EXPERIMENTAL
Intervention: 0.25% prednicarbate cream used twice daily over 5 days
Number of subjects: 143

Group type: COMPARATOR
Intervention: 0.25% prednicarbate cream with didecyldimethylammoniumchloride
Number of subjects: 143
Study: 2937812

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 750 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 1,000 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (all doses)
Number of subjects: 10
Study: 31232530

Group type: EXPERIMENTAL
Intervention: rHuEPO (epoetin β)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: ABP
Number of subjects: 48

Group type: COMPARATOR
Intervention: Urine assays
Number of subjects: 48
Study: 29338124

Group type: EXPERIMENTAL
Intervention: HC (Hot Compresses)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: HC plus tobramycin
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: HC plus tobramycin/dexamethasone
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Lesions that completely resolved
Number of subjects: 149
Study: 27814869

Group type: EXPERIMENTAL
Intervention: Neurodynamic treatment (four sessions over two weeks comprising passive lumbar foramen opening and neurodynamic sliders plus home exercises)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Advice to remain active (control group)
Number of subjects: 60
Study: 25357122

Group type: EXPERIMENTAL
Intervention: Dog culling
Number of subjects: 1105

Group type: COMPARATOR
Intervention: Insecticide spraying
Number of subjects: 1105

Group type: COMPARATOR
Intervention: Combination of spraying and eliminating dogs
Number of subjects: 1105

Group type: COMPARATOR
Intervention: Nothing (control group)
Number of subjects: 1105
Study: 23837404

Group type: EXPERIMENTAL
Intervention: Deworming and weekly iron supplementation for 6 months
Number of subjects: 1190

Group type: COMPARATOR
Intervention: Placebo for both anthelmintic and iron
Number of subjects: 1190
Study: 20649879

Group type: EXPERIMENTAL
Intervention: Lateral DXA for aortic vascular calcification (VC) measurement
Number of subjects: 44

Group type: COMPARATOR
Intervention: CT for aortic vascular calcification (VC) measurement
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: DXA for lumbar spine BMD measurement
Number of subjects: 44
Study: 18069097

Group type: EXPERIMENTAL
Intervention: RTS,S/AS02A vaccine
Number of subjects: 2022

Group type: COMPARATOR
Intervention: Control group (Engerix-B, Prevnar, Hiberix)
Number of subjects: 2022
Study: 16380288

Group type: EXPERIMENTAL
Intervention: Behavioural graded activity programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual therapy
Number of subjects: 0
Study: 12745616

Group type: EXPERIMENTAL
Intervention: NIV initiated after detecting more than 15 periods of nocturnal desaturation/hour by NPO (Group 2)
Number of subjects: 64

Group type: COMPARATOR
Intervention: NIV initiated after detecting early signs of diurnal respiratory insufficiency (Group 1)
Number of subjects: 64
Study: 10933355

Group type: EXPERIMENTAL
Intervention: Ramipril (5-10 mg daily)
Number of subjects: 617

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 617
Study: 9024334

Group type: EXPERIMENTAL
Intervention: Cholinergic agents (cholinesterase inhibitors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antioxidants, monoamine oxidase‐B inhibitors, cholinesterase inhibitors, anti‐inflammatory agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychosocial interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drugs that improve cognition
Number of subjects: 0
Study: 1316061

Group type: EXPERIMENTAL
Intervention: Lomefloxacin 400 mg orally 2‐6 hours prior to surgery
Number of subjects: 499

Group type: COMPARATOR
Intervention: Cefotaxime 1 g intravenously or intramuscularly 30‐90 minutes preoperatively
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Lomefloxacin concentrations measured in prostate tissue
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Adverse events reported
Number of subjects: 499
Study: 7462679

Group type: EXPERIMENTAL
Intervention: 8-methoxypsoralen (8-MOP) 0.3 mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 8-methoxypsoralen (8-MOP) 0.6 mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 8-methoxypsoralen (8-MOP) 0.9 mg/kg
Number of subjects: 8
Study: 31129017

Group type: EXPERIMENTAL
Intervention: Latarjet procedure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Iliac crest bone graft transfer (ICBGT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 60
Study: 28741653

Group type: EXPERIMENTAL
Intervention: Chloral hydrate syrup 50 mg.kg-1
Number of subjects: 196

Group type: COMPARATOR
Intervention: Intranasal saline spray (control)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Intranasal dexmedetomidine spray 3 μg.kg-1
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Chloral hydrate syrup and placebo spray
Number of subjects: 196
Study: 25321659

Group type: EXPERIMENTAL
Intervention: Omega-3 supplements (4.0 g/d eicosapentaenoic acid and 2.0 g/d docosahexaenoic acid)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Omega-3 supplements
Number of subjects: 23
Study: 24099358

Group type: EXPERIMENTAL
Intervention: Methylphenidate 10 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Methylphenidate 40 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 21717778

Group type: EXPERIMENTAL
Intervention: Red-hot filiform needle puncturing
Number of subjects: 200

Group type: COMPARATOR
Intervention: Routine filiform needle puncturing
Number of subjects: 200
Study: 19303968

Group type: EXPERIMENTAL
Intervention: Pulsatile intravenous insulin therapy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard insulin treatment
Number of subjects: 19
Study: 17309744

Group type: EXPERIMENTAL
Intervention: Formocresol (FC)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate (MTA)
Number of subjects: 126
Study: 17217712

Group type: EXPERIMENTAL
Intervention: xuezhikang (1200 mg/d)
Number of subjects: 100

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 100
Study: 14513420

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy regimen 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy regimen 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy regimen 3
Number of subjects: 0
Study: 10472873

Group type: EXPERIMENTAL
Intervention: 400 microg of intravaginal misoprostol, 3-hour interval
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 600 microg of intravaginal misoprostol, 2-hour interval
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 800 microg of intravaginal misoprostol, 2-hour interval
Number of subjects: 180

Group type: COMPARATOR
Intervention: 400 microg of intravaginal misoprostol
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 600 microg of intravaginal misoprostol
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 800 microg of intravaginal misoprostol
Number of subjects: 180

Group type: COMPARATOR
Intervention: 400 microg vs 800 microg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 600 microg and 800 microg
Number of subjects: 180
Study: 8696797

Group type: EXPERIMENTAL
Intervention: Verbal abuse, high overall activity level, standing uncomfortably close to the intended victim
Number of subjects: 62

Group type: COMPARATOR
Intervention: Non-aggressive controls
Number of subjects: 62
Study: 1935017

Group type: EXPERIMENTAL
Intervention: Panic disorder subjects
Number of subjects: 82

Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 82
Study: 6750781

Group type: EXPERIMENTAL
Intervention: Oral zinc sulphate
Number of subjects: 22
Study: 31595603

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: Thermo-coagulation
Number of subjects: 1023
Study: 29483065

Group type: EXPERIMENTAL
Intervention: Web-based beginners' running intervention delivered via a closed Facebook group (n=41)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group received a hard copy of the running program (n=48)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 89
Study: 27262236

Group type: EXPERIMENTAL
Intervention: Partial ileal bypass (PIB)
Number of subjects: 838

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Partial ileal bypass (PIB) including prediabetes
Number of subjects: 838

Group type: COMPARATOR
Intervention: Control group including prediabetes
Number of subjects: 838
Study: 26029816

Group type: EXPERIMENTAL
Intervention: Inactivated hepatitis A vaccine (Havrix™, GSK, Belgium)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (adults aged 20–30 years)
Number of subjects: 160
Study: 23796284

Group type: EXPERIMENTAL
Intervention: Trabectedin plus pegylated liposomal doxorubicin (PLD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: PLD alone
Number of subjects: 0
Study: 19909979

Group type: EXPERIMENTAL
Intervention: Fludrocortisone (0.2 mg/d)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Spironolactone (100 mg/d)
Number of subjects: 64
Study: 18227107

Group type: EXPERIMENTAL
Intervention: Studies reporting allocation concealment post-CONSORT statement
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Treatment effects in trials with allocation concealment
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Effect size over time
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Precision of studies over time
Number of subjects: 94
Study: 15840761

Group type: EXPERIMENTAL
Intervention: Low dose of diazepam
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 12574578

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO) at 2.5 ATA for 60 minutes
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham treatment at 1.14 ATA
Number of subjects: 33
Study: 10094976

Group type: EXPERIMENTAL
Intervention: 0.03 microgram/kg rHuIL-12 (n = 16)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.1 microgram/kg rHuIL-12 (n = 14)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.25 microgram/kg rHuIL-12 (n = 15)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.5 microgram/kg rHuIL-12 (n = 15)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: rHuIL-12 (all doses)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: rHuIL-12 (0.5 microgram/kg)
Number of subjects: 60
Study: 9050655

Group type: EXPERIMENTAL
Intervention: Suture technique (group 1)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Mesh and staples technique (group 2)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Both procedures
Number of subjects: 69
Study: 1752017

Group type: EXPERIMENTAL
Intervention: Isoflurane at 0.65 MAC or 1.25 MAC
Number of subjects: 25

Group type: COMPARATOR
Intervention: Desflurane at 0.65 MAC or 1.25 MAC
Number of subjects: 25
Study: 7104587

Group type: EXPERIMENTAL
Intervention: DDAVP
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31171016

Group type: EXPERIMENTAL
Intervention: Pomegranate juice (125 mL taken twice daily for 12 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (125 mL taken twice daily for 12 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pomegranate juice
Number of subjects: 0
Study: 27888696

Group type: EXPERIMENTAL
Intervention: Underwater walking training
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Land-based walking training
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (underwater walking training)
Number of subjects: 34
Study: 25348686

Group type: EXPERIMENTAL
Intervention: KingV-Guideless
Number of subjects: 47

Group type: COMPARATOR
Intervention: AWS
Number of subjects: 47

Group type: COMPARATOR
Intervention: KingV-Guided
Number of subjects: 47
Study: 24130219

Group type: EXPERIMENTAL
Intervention: Biodegradable system (Inion CPS)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Titanium group (KLS Martin)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 230
Study: 20934829

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol (1 g)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intramuscular piroxicam (20 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 19193505

Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 17530948

Group type: EXPERIMENTAL
Intervention: Half squat with vibration (HSV)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Half squat (HS)
Number of subjects: 17
Study: 15357694

Group type: EXPERIMENTAL
Intervention: Soya dietary intervention (2 servings per day)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group (0.2 servings of soya per day)
Number of subjects: 206
Study: 11410192

Group type: EXPERIMENTAL
Intervention: Deltamethrin insecticide treatment applied to livestock during the malaria transmission seasons.
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Deltamethrin insecticide treatment applied to livestock.
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Deltamethrin insecticide treatment applied to livestock in a highly endemic settlement.
Number of subjects: 6
Study: 9404682

Group type: COMPARATOR
Intervention: Lithium carbonate treatment with diet only (Group I)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Lithium carbonate treatment with oral hypoglycemic agents (OHA) (Group II)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Lithium carbonate treatment with insulin (Group III)
Number of subjects: 38
Study: 8234998

Group type: COMPARATOR
Intervention: Nitroglycerin patches (10 mg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Continuous treatment with nitroglycerin patches
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intermittent treatment with nitroglycerin patches
Number of subjects: 10
Study: 3548602

Group type: EXPERIMENTAL
Intervention: Elemental diet (Flexical)
Number of subjects: 17

Group type: COMPARATOR
Intervention: High dose steroid regimen
Number of subjects: 17
Study: 31006876

Group type: EXPERIMENTAL
Intervention: Teduglutide
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 29477584

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 151
Study: 27798020

Group type: EXPERIMENTAL
Intervention: Outpatient management with indwelling pleural catheter (IPC) and talc pleurodesis
Number of subjects: 142

Group type: COMPARATOR
Intervention: Usual inpatient management with chest drain and talc pleurodesis
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Outpatient management with IPC and talc pleurodesis
Number of subjects: 142
Study: 25047497

Group type: EXPERIMENTAL
Intervention: Lobeglitazone 0.5 mg with ketoconazole (9 doses of 200 mg pretreatment twice daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lobeglitazone 0.5 mg without ketoconazole
Number of subjects: 24
Study: 22418661

Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted vaccines
Number of subjects: 1357

Group type: COMPARATOR
Intervention: Nonadjuvanted vaccines
Number of subjects: 1357

Group type: EXPERIMENTAL
Intervention: Vaccine with 7.5 µg antigen and full dose of MF59
Number of subjects: 1357
Study: 19536599

Group type: EXPERIMENTAL
Intervention: Robotic assistance (da Vinci)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Laparoscopic instruments
Number of subjects: 34
Study: 18025250

Group type: EXPERIMENTAL
Intervention: Atomoxetine (10-week treatment)
Number of subjects: 536

Group type: COMPARATOR
Intervention: Placebo (10-week treatment)
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Investigator ratings
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Self-report scores
Number of subjects: 536
Study: 15884039

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control nonacupuncture protocol
Number of subjects: 14
Study: 12537199

Group type: EXPERIMENTAL
Intervention: High thoracic epidural analgesia (HTEA)
Number of subjects: 80
Study: 11303372

Group type: EXPERIMENTAL
Intervention: High dose interleukin-2 (IL-2) therapy, 720,000 IU/kg per dose i.v. in 15 minutes, administered in bolus for 2 weeks with a 1 week rest interval.
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High dose interleukin-2 (IL-2) therapy with prior autologous vaccines.
Number of subjects: 21
Study: 9175669

Group type: EXPERIMENTAL
Intervention: Threatened preterm delivery group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (uncomplicated pregnancy)
Number of subjects: 0